<p>Revvity Inc.（紐約證券交易所代碼：RVTY - 獲取免費報告）在目前覆蓋該股票的十四位分析師中獲得了 “適度買入” 的共識評級，MarketBeat.com 報道稱。一位投資分析師給予該股票賣出評級，五位分析師給予持有評級，八位分析師給予買入評級。在過去一年中更新了對該股票覆蓋的分析師中，平均一年目標價為 114.75 美元。</p>
<p>RVTY 最近成為多份研究報告的主題。巴克萊在 10 月 28 日的報告中將 Revvity 的目標價從 100.00 美元上調至 105.00 美元，並給予公司 “增持” 評級。古根海姆在 10 月 15 日的研究報告中開始覆蓋 Revvity 的股票，併為公司設定了 “中性” 評級。Evercore ISI 在 10 月 27 日的研究報告中重申了 “跑贏大盤” 評級，並對 Revvity 的股票設定了 108.00 美元的目標價。羅伯特·W·貝爾德在 10 月 28 日的報告中將 Revvity 的目標價從 122.00 美元上調至 123.00 美元，並給予該股票 “跑贏大盤” 評級。最後，美國銀行在 9 月 22 日的研究報告中將 Revvity 的目標價從 110.00 美元下調至 99.00 美元，並對該股票設定了 “買入” 評級。</p>
<p><strong>閲讀我們關於 Revvity 的最新研究報告</strong></p>
<h2>對 Revvity 的對沖基金看法</h2>
<p>大型投資者最近增加或減少了對公司的持股。T. Rowe Price Investment Management Inc.在第一季度將其在 Revvity 的股份增加了 8.5%。T. Rowe Price Investment Management Inc.目前擁有 22,515,711 股公司股票，價值 2,382,163,000 美元，在上一季度購買了額外的 1,754,403 股。先鋒集團在第一季度將其在 Revvity 的持股增加了 0.6%。先鋒集團目前擁有 14,382,849 股公司股票，價值 1,521,705,000 美元，在此期間購買了額外的 92,638 股。Price T Rowe Associates Inc. MD 在第一季度將其在 Revvity 的持股增加了 25.3%。Price T Rowe Associates Inc. MD 目前擁有 9,563,911 股公司股票，價值 1,011,863,000 美元，在此期間購買了額外的 1,932,314 股。EdgePoint Investment Group Inc.在第三季度將其在 Revvity 的股份增加了 26.3%。EdgePoint Investment Group Inc.目前擁有 8,574,280 股公司股票，價值 751,536,000 美元，在上一季度購買了額外的 1,784,620 股。最後，景順有限公司在第三季度將其在 Revvity 的持股增加了 15.7%。景順有限公司目前擁有 2,553,515 股公司股票，價值 223,816,000 美元，在此期間獲得了額外的 346,313 股。對沖基金和其他機構投資者擁有公司 86.65% 的股票。</p>
<h2>Revvity 股票下跌 1.7%</h2>
<p>RVTY 股票在週五開盤價為 100.81 美元。該公司的市值為 114.3 億美元，市盈率為 50.66，市盈增長比率為 3.39，貝塔值為 1.06。該公司的債務與股本比率為 0.36，速動比率為 1.44，流動比率為 1.75。該公司的 50 日移動平均線為 95.01 美元，200 日移動平均線為 92.97 美元。Revvity 的 52 周低點為 81.36 美元，52 周高點為 128.29 美元。</p>
<p>Revvity（紐約證券交易所代碼：RVTY - 獲取免費報告）在 10 月 27 日發佈了季度財報。該公司報告季度每股收益為 1.18 美元，超出共識預期的 1.14 美元，超出幅度為 0.04 美元。Revvity 的淨利潤率為 8.44%，股本回報率為 7.52%。該公司在本季度的收入為 6.9895 億美元，而分析師預期為 6.9975 億美元。去年同期，該公司的每股收益為 1.28 美元。與去年同期相比，該公司的季度收入增長了 2.2%。Revvity 已將其 2025 財年的指導目標設定為 4.900-5.000 美元每股收益。整體來看，分析師預測 Revvity 在當前年度的每股收益為 4.94 美元。</p>
<h2>Revvity 宣佈分紅</h2>
<p>該公司還最近披露了季度分紅，將於 2 月 6 日（星期五）支付。1 月 16 日（星期五）的登記投資者將獲得每股 0.07 美元的分紅。除息日期為 1 月 16 日（星期五）。這代表着年化分紅為 0.28 美元，分紅收益率為 0.3%。Revvity 的派息比率為 14.07%。</p>
<p>Revvity 宣佈其董事會在 10 月 27 日啓動了一項股票回購計劃，允許公司回購 10 億美元的股票。該回購授權允許公司通過公開市場購買最多 8.7% 的股份。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>Revvity 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Revvity, Inc 在美洲、歐洲和亞洲及國際上提供健康科學解決方案、技術和服務。生命科學部門提供儀器、試劑、信息學、軟件、訂閲、檢測、成像技術、保修、培訓和服務。其診斷部門提供儀器、試劑、檢測平台和軟件產品，用於早期檢測遺傳疾病，如妊娠和早期兒童疾病，以及診斷市場中的傳染病檢測。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票比 Revvity 更好</li>
<li>上升趨勢股票解釋：學習如何利用上升趨勢進行交易</li>
<li>火箭實驗室的大反彈？分析師建議抄底</li>
<li>為什麼投資 5G？如何投資 5G 股票</li>
<li>Meta 的人工智能時刻？新的 SAM 3 模型讓華爾街轉向看漲</li>
<li>最具波動性的股票，投資者需要知道的</li>
<li>Snowflake 股票：聰明投資者現在正在購買的下跌</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Revvity 嗎？</h2>
<p>在考慮 Revvity 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Revvity 並不在名單上。</p>
<p>雖然 Revvity 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

RVTY

<p>Revvity Inc.（紐約證券交易所代碼：RVTY）獲得 14 位分析師的共識 “適度買入” 評級，平均目標價為 114.75 美元。最近的分析師行動包括巴克萊將目標價上調至 105 美元，羅伯特·W·貝爾德上調至 123 美元。該股票開盤價為 100.81 美元，市值為 114.3 億美元。Revvity 報告第三季度每股收益為 1.18 美元，超出預期。公司宣佈了一項 10 億美元的股票回購計劃</p>

<p>Revvity Inc. (NYSE:RVTY - Get Free Report) has earned a consensus rating of &#34;Moderate Buy&#34; from the fourteen analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $114.75.</p>
<div class="lb-trans"><p>Revvity Inc.（紐約證券交易所代碼：RVTY - 獲取免費報告）在目前覆蓋該股票的十四位分析師中獲得了 “適度買入” 的共識評級，MarketBeat.com 報道稱。一位投資分析師給予該股票賣出評級，五位分析師給予持有評級，八位分析師給予買入評級。在過去一年中更新了對該股票覆蓋的分析師中，平均一年目標價為 114.75 美元。</p>
</div><p>RVTY has been the subject of a number of research reports. Barclays upped their target price on shares of Revvity from $100.00 to $105.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, October 28th. Guggenheim started coverage on shares of Revvity in a research report on Wednesday, October 15th. They set a &#34;neutral&#34; rating for the company. Evercore ISI restated an &#34;outperform&#34; rating and issued a $108.00 price objective on shares of Revvity in a research note on Monday, October 27th. Robert W. Baird raised their target price on Revvity from $122.00 to $123.00 and gave the stock an &#34;outperform&#34; rating in a report on Tuesday, October 28th. Finally, Bank of America lowered their target price on Revvity from $110.00 to $99.00 and set a &#34;buy&#34; rating on the stock in a research report on Monday, September 22nd.</p>
<div class="lb-trans"><p>RVTY 最近成為多份研究報告的主題。巴克萊在 10 月 28 日的報告中將 Revvity 的目標價從 100.00 美元上調至 105.00 美元，並給予公司 “增持” 評級。古根海姆在 10 月 15 日的研究報告中開始覆蓋 Revvity 的股票，併為公司設定了 “中性” 評級。Evercore ISI 在 10 月 27 日的研究報告中重申了 “跑贏大盤” 評級，並對 Revvity 的股票設定了 108.00 美元的目標價。羅伯特·W·貝爾德在 10 月 28 日的報告中將 Revvity 的目標價從 122.00 美元上調至 123.00 美元，並給予該股票 “跑贏大盤” 評級。最後，美國銀行在 9 月 22 日的研究報告中將 Revvity 的目標價從 110.00 美元下調至 99.00 美元，並對該股票設定了 “買入” 評級。</p>
</div><p><strong>Read Our Latest Research Report on Revvity</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 Revvity 的最新研究報告</strong></p>
</div><h2>Hedge Funds Weigh In On Revvity</h2>
<div class="lb-trans"><h2>對 Revvity 的對沖基金看法</h2>
</div><p>Large investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. increased its stake in shares of Revvity by 8.5% in the first quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company's stock worth $2,382,163,000 after purchasing an additional 1,754,403 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Revvity by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company's stock worth $1,521,705,000 after buying an additional 92,638 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Revvity by 25.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company's stock worth $1,011,863,000 after buying an additional 1,932,314 shares during the period. EdgePoint Investment Group Inc. increased its stake in Revvity by 26.3% in the 3rd quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company's stock worth $751,536,000 after buying an additional 1,784,620 shares in the last quarter. Finally, Invesco Ltd. raised its holdings in Revvity by 15.7% during the third quarter. Invesco Ltd. now owns 2,553,515 shares of the company's stock valued at $223,816,000 after acquiring an additional 346,313 shares during the period. Hedge funds and other institutional investors own 86.65% of the company's stock.</p>
<div class="lb-trans"><p>大型投資者最近增加或減少了對公司的持股。T. Rowe Price Investment Management Inc.在第一季度將其在 Revvity 的股份增加了 8.5%。T. Rowe Price Investment Management Inc.目前擁有 22,515,711 股公司股票，價值 2,382,163,000 美元，在上一季度購買了額外的 1,754,403 股。先鋒集團在第一季度將其在 Revvity 的持股增加了 0.6%。先鋒集團目前擁有 14,382,849 股公司股票，價值 1,521,705,000 美元，在此期間購買了額外的 92,638 股。Price T Rowe Associates Inc. MD 在第一季度將其在 Revvity 的持股增加了 25.3%。Price T Rowe Associates Inc. MD 目前擁有 9,563,911 股公司股票，價值 1,011,863,000 美元，在此期間購買了額外的 1,932,314 股。EdgePoint Investment Group Inc.在第三季度將其在 Revvity 的股份增加了 26.3%。EdgePoint Investment Group Inc.目前擁有 8,574,280 股公司股票，價值 751,536,000 美元，在上一季度購買了額外的 1,784,620 股。最後，景順有限公司在第三季度將其在 Revvity 的持股增加了 15.7%。景順有限公司目前擁有 2,553,515 股公司股票，價值 223,816,000 美元，在此期間獲得了額外的 346,313 股。對沖基金和其他機構投資者擁有公司 86.65% 的股票。</p>
</div><h2>Revvity Stock Down 1.7%</h2>
<div class="lb-trans"><h2>Revvity 股票下跌 1.7%</h2>
</div><p>RVTY stock opened at $100.81 on Friday. The company has a market cap of $11.43 billion, a price-to-earnings ratio of 50.66, a P/E/G ratio of 3.39 and a beta of 1.06. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 1.75. The business's 50-day moving average is $95.01 and its two-hundred day moving average is $92.97. Revvity has a fifty-two week low of $81.36 and a fifty-two week high of $128.29.</p>
<div class="lb-trans"><p>RVTY 股票在週五開盤價為 100.81 美元。該公司的市值為 114.3 億美元，市盈率為 50.66，市盈增長比率為 3.39，貝塔值為 1.06。該公司的債務與股本比率為 0.36，速動比率為 1.44，流動比率為 1.75。該公司的 50 日移動平均線為 95.01 美元，200 日移動平均線為 92.97 美元。Revvity 的 52 周低點為 81.36 美元，52 周高點為 128.29 美元。</p>
</div><p>Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, October 27th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The firm had revenue of $698.95 million during the quarter, compared to analyst estimates of $699.75 million. During the same quarter in the prior year, the firm earned $1.28 EPS. The business's revenue for the quarter was up 2.2% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. As a group, analysts forecast that Revvity will post 4.94 earnings per share for the current year.</p>
<div class="lb-trans"><p>Revvity（紐約證券交易所代碼：RVTY - 獲取免費報告）在 10 月 27 日發佈了季度財報。該公司報告季度每股收益為 1.18 美元，超出共識預期的 1.14 美元，超出幅度為 0.04 美元。Revvity 的淨利潤率為 8.44%，股本回報率為 7.52%。該公司在本季度的收入為 6.9895 億美元，而分析師預期為 6.9975 億美元。去年同期，該公司的每股收益為 1.28 美元。與去年同期相比，該公司的季度收入增長了 2.2%。Revvity 已將其 2025 財年的指導目標設定為 4.900-5.000 美元每股收益。整體來看，分析師預測 Revvity 在當前年度的每股收益為 4.94 美元。</p>
</div><h2>Revvity Announces Dividend</h2>
<div class="lb-trans"><h2>Revvity 宣佈分紅</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, January 16th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity's payout ratio is 14.07%.</p>
<div class="lb-trans"><p>該公司還最近披露了季度分紅，將於 2 月 6 日（星期五）支付。1 月 16 日（星期五）的登記投資者將獲得每股 0.07 美元的分紅。除息日期為 1 月 16 日（星期五）。這代表着年化分紅為 0.28 美元，分紅收益率為 0.3%。Revvity 的派息比率為 14.07%。</p>
</div><p>Revvity announced that its board has initiated a stock buyback program on Monday, October 27th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to purchase up to 8.7% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>Revvity 宣佈其董事會在 10 月 27 日啓動了一項股票回購計劃，允許公司回購 10 億美元的股票。該回購授權允許公司通過公開市場購買最多 8.7% 的股份。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>Revvity Company Profile</h2>
<div class="lb-trans"><h2>Revvity 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.</p>
<div class="lb-trans"><p>Revvity, Inc 在美洲、歐洲和亞洲及國際上提供健康科學解決方案、技術和服務。生命科學部門提供儀器、試劑、信息學、軟件、訂閲、檢測、成像技術、保修、培訓和服務。其診斷部門提供儀器、試劑、檢測平台和軟件產品，用於早期檢測遺傳疾病，如妊娠和早期兒童疾病，以及診斷市場中的傳染病檢測。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Revvity</li>
<li>Uptrend Stocks Explained: Learn How to Trade Using Uptrends</li>
<li>Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift</li>
<li>Why Invest in 5G? How to Invest in 5G Stocks</li>
<li>Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish</li>
<li>Most Volatile Stocks, What Investors Need to Know</li>
<li>Snowflake Stock: The Dip That Smart Investors Are Buying Right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Revvity 更好</li>
<li>上升趨勢股票解釋：學習如何利用上升趨勢進行交易</li>
<li>火箭實驗室的大反彈？分析師建議抄底</li>
<li>為什麼投資 5G？如何投資 5G 股票</li>
<li>Meta 的人工智能時刻？新的 SAM 3 模型讓華爾街轉向看漲</li>
<li>最具波動性的股票，投資者需要知道的</li>
<li>Snowflake 股票：聰明投資者現在正在購買的下跌</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=RVTY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Revvity Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Revvity 嗎？</h2>
</div><p>Before you consider Revvity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Revvity 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Revvity 並不在名單上。</p>
</div><p>While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Revvity 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Revvity 公司（NYSE 代碼：RVTY）被分析師一致評為 “適度買入”